APPLIED DNA SCIENCES INC (42) | Business Finance (28)

Browse by Subcategory

Recent Contracts

Form of Securities Purchase Agreement (Filed With SEC on January 11, 2021)
Letter Agreement, dated October 9, 2020, by and among Applied DNA Sciences, Inc., Dillon Hill Capital, LLC, and Delaware Trust Company, as Collateral Agent (Filed With SEC on October 14, 2020)
Registration Rights Agreement, dated October 7, 2020, by and between Applied DNA Sciences, Inc. and Dillon Hill Investment Company LLC (Filed With SEC on October 14, 2020)
Form of Common Stock Purchase Warrant (Filed With SEC on October 14, 2020)
Underwriting Agreement entered into by and between Applied DNA Sciences, Inc. and Maxim Group LLC, as Representative of the Underwriters listed in Schedule I hereto, dated... (Filed With SEC on November 14, 2019)
Form of Subscription Agreement between investors and Applied DNA Sciences, Inc., dated August 22, 2019 (Filed With SEC on August 26, 2019)
Second Amendment to Intellectual Property Security Agreement, dated July 19, 2019 by APDN (B.V.I.) Inc. in favor of Delaware Trust Company as collateral agent for the secured... (Filed With SEC on August 13, 2019)
Amendment to Secured Convertible Notes, dated July 16, 2019 by and among Applied DNA Sciences, Inc. and the investors named on the signature page thereof (Filed With SEC on July 17, 2019)
Registration Rights Agreement, dated October 7, 2020, by and between Applied DNA Sciences, Inc. and Dillon Hill Capital, LLC (Filed With SEC on October 14, 2020)
Warrant Exercise Agreement, dated October 7, 2020, by and between Applied DNA Sciences, Inc. and Dillon Hill Investment Company LLC (Filed With SEC on October 14, 2020)
Warrant Exercise Agreement, dated October 7, 2020, by and between Applied DNA Sciences, Inc. and Dillon Hill Capital, LLC (Filed With SEC on October 14, 2020)
Warrant Agreement, dated November 15, 2019, between Applied DNA Sciences, Inc. and American Stock Transfer & Trust Company, LLC (Filed With SEC on November 18, 2019)
Form of warrant agreement between Applied DNA Sciences, Inc. and American Stock Transfer & Trust Company, LLC (Filed With SEC on November 14, 2019)
Form of pre-funded warrant (Filed With SEC on November 14, 2019)
Form of Underwriting Agreement (Filed With SEC on November 8, 2019)
Form of Underwriting Agreement (Filed With SEC on November 1, 2019)
Form of Underwriting Agreement (Filed With SEC on October 25, 2019)
Form of pre-funded warrant (Filed With SEC on October 25, 2019)
Form of warrant agreement between Applied DNA Sciences, Inc. and American Stock Transfer & Trust Company, LLC (Filed With SEC on October 25, 2019)
Second Amendment to Intellectual Property Security Agreement, dated July 19, 2019 by the Company in favor of Delaware Trust Company as collateral agent for the secured parties... (Filed With SEC on August 13, 2019)
Second Omnibus Amendment Agreement, dated July 19, 2019 by and among the Company, APDN (B.V.I.) Inc., and Delaware Trust Company, as collateral agent for the benefit of the buyers... (Filed With SEC on August 13, 2019)
Asset Purchase Agreement, dated July 29, 2019 by and between LineaRX, Inc. and Vitatex Inc (Filed With SEC on August 12, 2019)
Securities Purchase Agreement, dated July 16, 2019 by and among Applied DNA Sciences, Inc. and the investor named on the signature page thereof (Filed With SEC on July 17, 2019)
Registration Rights Agreement, dated July 16, 2019 by and among Applied DNA Sciences, Inc. and the investor named on the signature page thereof (Filed With SEC on July 17, 2019)
Form of Secured Convertible Note (Filed With SEC on July 17, 2019)
First Amendment to Intellectual Property Security Agreement, dated February 26, 2019, between the Company and Delaware Trust Company as collateral agent for the benefit of the... (Filed With SEC on May 9, 2019)
First Amendment to Intellectual Property Security Agreement, dated February 26, 2019, between APDN (B.V.I.) Inc. and Delaware Trust Company as collateral agent for the benefit of... (Filed With SEC on May 9, 2019)
Omnibus Amendment Agreement, dated February 26, 2019, among the Company, APDN (B.V.I.), Inc., and Delaware Trust Company as collateral agent for the benefit of the buyers listed... (Filed With SEC on May 9, 2019)